Our findings suggested that the HG/STAT3/HIF-1α signaling pathway might be an important supplement for the mechanism of PF during long-term PD treatment and STAT3 inhibitor could be a new therapeutic strategy for the PF. This evidence concerns the gene STAT3 and pemphigus foliaceus.